Aloke K Dutta
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 26, 2026
Protection Against Cellular Toxicity from Rotenone Treatment by the Neuroprotective, Novel Multifunctional Antiparkinsonian Drug D-512.Pranay Ravipati, Liping Xu, Deepthi Yedlapudi
|Nov 06, 2024
Novel Piperazine Based Compounds Target Alzheimer's Disease Relevant Amyloid β42 and Tau Derived Peptide AcPHF6, and the Lead Molecule Increases Viability in the Flies Expressing Human Tau Protein.Christopher Armstrong, Dan Luo, Anna Gretzinger
|Feb 07, 2023
D-685 Reverses Motor Deficits and Reduces Accumulation of Human α-Synuclein Protein in Two Different Parkinson's Disease Animal Models.Aloke K Dutta, Christopher Armstrong, Dan Luo
|Apr 12, 2021
Novel Potent Dopamine-Norepinephrine and Triple Reuptake Uptake Inhibitors Based on Asymmetric Pyran Template and Their Molecular Interactions with Monoamine Transporters.Soumava Santra, Sandhya Kortagere, Seenuvasan Vedachalam
|Oct 11, 2018
Design, Synthesis, and Pharmacological Characterization of Carbazole Based Dopamine Agonists as Potential Symptomatic and Neuroprotective Therapeutic Agents for Parkinson's Disease.Asma Elmabruk, Banibrata Das, Deepthi Yedlapudi
|Jan 21, 2017
A Novel Iron(II) Preferring Dopamine Agonist Chelator as Potential Symptomatic and Neuroprotective Therapeutic Agent for Parkinson's Disease.Banibrata Das, Ashoka Kandegedara, Liping Xu
Pageof 1
